Skip to content

NGIO 2024

Event Information:


June 20th and 21st, 2024

Boston MA, United States

Related Models & Services

CD34+ Humanized Mouse
Immuno-Oncology Models

TransCure BioServices at NGIO 2024 – Leading Innovation in Immuno-Oncology

TransCure BioServices is excited to announce our participation at the upcoming NGIO Conference, held in Boston on June 20-21, 2024. As pioneers in the field of immuno-oncology, we are eager to showcase our latest advancements and explore new horizons in cancer research thanks to our preclinical humanized mice models.

Join us at NGIO 2024 where Philippe Michon, our North America Business Developer, will represent TransCure BioServices. We will highlight our cutting-edge research and development in the realm of humanized mouse models, which have been instrumental in progressing the field of immuno-oncology.

See you at NGIO!

Philippe MICHON - Transcure BioServicesAttending in person for TransCure bioServices:

Philippe Michon, Business Development

Philippe Michon holds an MBA from H.E.C. Montreal and joined Transcure in 2024. Prior he worked with XenTech, a preclinical oncology CRO focusing on PDX technology, as Head of BD. He’s an experienced and trusted professional with established history of technology software and CRO/Service sales achievements in the R&D Life Sciences arena. 20+ years selling innovative digital solutions including business development and strategic planning activities, as well as providing leadership in the areas of selling, reporting, forecasting, budgeting, pricing, and contract negotiation. A proven team player with good interpersonal, communication and organizational skills with a record of successful dynamism and combined entrepreneurial management.

This event has concluded